Purchased 4,015,452 Class A shares and 1,077,764 pre-funded warrants in the August 2025 Private Placement
| Officer | Age | In this role | 2025 pay | Source |
|---|---|---|---|---|
|
Benjamin J. Zeskind
Also a director
Co-Founder, President, Chief Executive Officer, Director
|
44 |
Since 2008
18 years
|
$1,660,612 | |
|
Andrew Gengos
Chief Financial Officer
Title from the Form 4 dated Jul 16, 2026
|
Not stated | Not stated | Not reported | |
|
Harold E. Brakewood
Chief Business Officer
|
61 |
Since 2023
3 years
|
Not reported | |
|
Brett Hall
Chief Scientific Officer
|
57 |
Since 2019
7 years
|
$1,289,504 | |
|
Michael D. Bookman
Chief Legal Officer, Secretary
|
39 |
Since 2023
3 years
|
$890,362 | |
|
Igor Matushansky
Chief Medical Officer
|
53 |
Since 2025
1 year
|
Not reported | |
|
Mallory Morales
Senior Vice President Finance, Chief Accounting Officer
|
42 |
Since 2026
this year
|
Not reported | |
|
Leah R. Neufeld
Chief People Officer
|
53 |
Since 2022
4 years
|
Not reported |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
From the proxy statement filed Apr 20, 2026 · updated by the 8-K of Nov 9, 2026
| Director | Age | On board | Independent | Committees | Other public boards | 2025 pay | Source |
|---|---|---|---|---|---|---|---|
|
Thomas J. Schall, Ph.D.
Board chair
|
66 |
2024
2 years
|
Independent |
Audit Committee
|
None stated | $104,893 | |
|
Benjamin J. Zeskind, Ph.D.
CEO
|
44 |
2008
18 years
|
Not stated | None stated | None stated | Paid as CEO | |
|
Peter Feinberg
|
65 |
2021
5 years
|
Independent |
Audit Committee
Nominating and Corporate Governance Committee
|
None stated | $103,379 | |
|
Laurie B. Keating
|
72 |
2021
5 years
|
Independent | None stated | PepGen Inc. | $106,811 | |
|
Robert J. Carpenter
|
81 |
2009
17 years
|
Independent |
Compensation Committee
|
None stated | $93,521 | |
|
Diana F. Hausman, M.D.
|
63 |
2022
4 years
|
Independent | None stated | None stated | $101,521 | |
|
Grant C. Bogle
Joined Nov 9, 2026
|
- | - | - | - | - | - |
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.
Purchased 4,015,452 Class A shares and 1,077,764 pre-funded warrants in the August 2025 Private Placement
Purchased 539,696 Class A shares in the August 2025 Private Placement
Purchased 7,679,476 Class A shares in the September 2025 Offering
Purchased 2,708,559 Class A shares in the September 2025 Offering
Purchased 541,711 Class A shares in the September 2025 Offering
Employed by the Company as Senior Manager, Logistics; received total compensation for fiscal year 2025
Indemnification agreements requiring the Company to indemnify directors and executive officers to the fullest extent permitted by Delaware law
Loading...